Gujarat Terce Laboratories informs about financial results

29 May 2018 Evaluate

Gujarat Terce Laboratories has informed that that at the meeting of the Board of Directors of the Company held today, May 29, 2018 at Ahmedabad, has approved the Audited Standalone Financial results of the Company for the year ended March 31, 2018, in terms of Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Guj. Terce Lab Share Price

48.05 0.06 (0.13%)
27-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.25
Dr. Reddys Lab 6241.60
Cipla 1480.95
Zydus Lifesciences 1063.45
Lupin 1584.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.